Trending:

 

All articles by  

  1. Johnson & Johnson

    Vect-Horus and Janssen partner for neurodegenerative disease treatment

    Vect-Horus has entered a research collaboration agreement with Johnson & Johnson subsidiary Janssen Pharmaceuticals for treating neurodegenerative diseases. The partnership…
    Read More…

    12 Dec

  2. Roche’s Tecentriq gets FDA priority review to treat small cell lung cancer

    The US Food and Drug Administration (FDA) has granted priority review for Roche’s Tecentriq (atezolizumab) in combination with chemotherapy for…
    Read More…

    6 Dec

  3. Deerfield buys AlivaMab Mouse technology developer Ablexis

    Investment management firm Deerfield has acquired Ablexis, a company that has developed AlivaMab Mouse technology, which is a transgenic mouse…
    Read More…

    25 Jun

  4. FDA accepts BMS’s application for non-small cell lung cancer treatment

    The US Food and Drug Administration (FDA) has accepted Bristol-Myers Squibb Company’s (BMY) supplemental biologics licence application (sBLA) for Opdivo…
    Read More…

    25 Jun

  5. Merck to distribute HistoCyte Laboratories’ cell line products

    Pharmaceutical company Merck has signed an agreement to become the exclusive multinational distributor of HistoCyte Laboratories’ portfolio of cell line…
    Read More…

    22 Jun

  6. Sugar can delay neurodegeneration caused by enzyme deficiency

    A team of researchers from Baylor College of Medicine in the US have found that a new therapeutic approach of…
    Read More…

    22 Jun

  7. Researchers identify brain metals that may precipitate Alzheimer’s

    A research team including members from Warwick’s School of Engineering has identified and characterised certain brain metals that may precipitate…
    Read More…

    22 Jun

  8. Natera and Institut Jules Bordet partner on breast cancer research

    Genetic testing company Natera has partnered with the Belgian Institut Jules Bordet to advance breast cancer research. The collaboration will…
    Read More…

    21 Jun

  9. Study finds drug reduces hearing loss in children with liver cancer

    A study has found that a new drug sodium thiosulphate (STS) can reduce hearing loss in children treated for hepatoblastoma,…
    Read More…

    21 Jun

  10. Roche to buy remaining stake in Foundation Medicine for $2.4bn

    Roche has signed a definitive agreement to acquire the outstanding shares of Foundation Medicine (FMI) for $2.4bn. The transaction values…
    Read More…

    21 Jun

Go Top